Skip to main content

Electra Therapeutics, Inc.

ETRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002088082

In the last 90 days, Electra Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding ETRA, Q2 2026

See all superinvestors

No superinvestor reported holding ETRA in Q2 2026.